Day J P, Hammer R P, Bergstrom D, Barany F
Department of Microbiology, Box 62, Hearst Microbiology Research Center, Strang Cancer Prevention Center,Joan and Sanford I. Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA.
Nucleic Acids Res. 1999 Apr 15;27(8):1819-27. doi: 10.1093/nar/27.8.1819.
A high sensitivity method for detecting low level mutations is under development. A PCR reaction is performed in which a restriction site is introduced in wild-type DNA by alteration of specific bases. Digestion of wild-type DNA by the cognate restriction endonuclease (RE) enriches for products with mutations within the recognition site. After reamplification, mutations are identified by a ligation detection reaction (LDR). This PCR/RE/LDR assay was initially used to detect PCR error in known wild-type samples. PCR error was measured in low |Deltap K a| buffers containing tricine, EPPS and citrate, as well as otherwise identical buffers containing Tris. PCR conditions were optimized to minimize PCR error using perfect match primers at the Msp I site in the p53 tumor suppressor gene at codon 248. However, since mutations do not always occur within pre-existing restriction sites, a generalized PCR/RE/LDR method requires the introduction of a new restriction site. In principle, PCR with mismatch primers can alter specific bases in a sequence and generate a new restriction site. However, extension from 3' mismatch primers may generate misextension products. We tested conversion of the Msp I (CCGG) site to a Taq I site (TCGA). Conversion was unsuccessful using a natural base T mismatch primer set. Conversion was successful when modified primers containing the 6 H,8 H -3, 4-dihydropyrimido[4,5- c ][1,2]oxazine-7-one (Q6) base at 3'-ends were used in three cycles of preconversion PCR prior to conversion PCR using the 3' natural base T primers. The ability of the pyrimidine analog Q6 to access both a T-like and C-like tautomer appears to greatly facilitate the conversion.
一种用于检测低水平突变的高灵敏度方法正在研发中。进行聚合酶链反应(PCR)时,通过特定碱基的改变在野生型DNA中引入一个限制性酶切位点。用同源限制性内切酶(RE)消化野生型DNA可富集识别位点内有突变的产物。再扩增后,通过连接检测反应(LDR)鉴定突变。这种PCR/RE/LDR检测法最初用于检测已知野生型样本中的PCR错误。在含有三羟甲基甘氨酸、3-(N-吗啉代)丙磺酸(EPPS)和柠檬酸盐的低|ΔpKa|缓冲液以及含有三羟甲基氨基甲烷(Tris)的其他相同缓冲液中测量PCR错误。使用p53肿瘤抑制基因第248密码子处Msp I位点的完全匹配引物优化PCR条件以尽量减少PCR错误。然而,由于突变并非总是发生在预先存在的限制性酶切位点内,通用的PCR/RE/LDR方法需要引入一个新的限制性酶切位点。原则上,使用错配引物的PCR可改变序列中的特定碱基并产生一个新的限制性酶切位点。然而,从3'错配引物延伸可能会产生错误延伸产物。我们测试了将Msp I(CCGG)位点转化为Taq I位点(TCGA)。使用天然碱基T错配引物组转化未成功。当在使用3'天然碱基T引物进行转化PCR之前,在三个预转化PCR循环中使用3'端含有6H,8H-3,4-二氢嘧啶并[4,5-c][1,2]恶嗪-7-酮(Q6)碱基的修饰引物时,转化成功。嘧啶类似物Q6能够形成T样和C样互变异构体,这似乎极大地促进了转化。